- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Relapsing-remitting multiple sclerosis (RRMS)
- Meeting Date: November 2019
- Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)
Dimethyl fumarate – November 2019
Dimethyl fumarate: Capsule (modified release) 120 mg, Capsule (modified release) 240 mg; Tecfidera®
Last updated
6 March 2020